Havrix 1440 IU Vaccine
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Havrix 1440 IU Vaccine is an inactivated hepatitis A vaccine. Its labelling describes it as being given to help protect against infection caused by the hepatitis A virus, which can cause serious liver disease, by prompting the immune system to produce antibodies against the virus.
Product Information
The following description reflects information associated with hepatitis A vaccine (inactivated) and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for active immunisation against hepatitis A virus infection
- The 1440 IU presentation is described for adults; a separate paediatric presentation is described for children
- A primary dose followed by a booster (commonly 6–12 months later) is described as needed for longer-term protection
Described Dosage & Administration
- Administered only by a doctor or nurse, as an intramuscular injection
- Given as a primary dose with a booster dose per the schedule set by the healthcare provider
- Both doses should be completed as advised for durable protection
Described Side Effects
Commonly described side effects include:
- Injection-site reactions (pain, redness, swelling)
- Headache
- Tiredness or drowsiness
- Loss of appetite
- Irritability (in children)
Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Any previous allergic reaction to a vaccine or vaccine component should be disclosed before administration
- Administration may be delayed during an acute febrile illness, per manufacturer guidance
- It does not treat an established hepatitis A infection and may not protect people already incubating the virus
- Pregnancy or breastfeeding should be discussed with the healthcare provider
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is an inactivated hepatitis A vaccine given to help protect against hepatitis A virus infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes a primary dose followed by a booster, commonly 6 to 12 months later, given by a healthcare professional.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.